Fol. Biol. 2021, 67, 16-27
https://doi.org/10.14712/fb2021067010016
T-Cell Activation: Post-Infection Diagnostic Tool for COVID-19
References
1. 2020) Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARSCoV immunological studies. Viruses 12, 254.
< , S. F., Quadeer, A. A., McKay, M. R. (https://doi.org/10.3390/v12030254>
2. 1990) The time course of the immune response to experimental coronavirus infection of man. Epidemiol. Infect. 105, 435-446.
< , K. A., Parry, H. F., Sergeant, M., Tyrrell, D. A. (https://doi.org/10.1017/S0950268800048019>
3. Cohen, A. N., Kessel, B. (2020) False positives in reverse transcription PCR testing for SARS-CoV-2. Preprint. medRxiv.
<https://doi.org/10.1101/2020.04.26.20080911>
4. Freeman, B., Lester, S., Mills, L., Rasheed, M. A. U., Moye, S., Abiona, O., Hutchinson, G. B., Morales-Betoulle, M., Krapinunaya, I., Gibbons, A., Chiang, C. F., Cannon, D., Klena, J., Johnson, J. A., Owen, S. M., Graham, B. S., Corbett, K. S., Thornburg, N. J. (2020) Validation of a SARSCoV- 2 spike protein ELISA for use in contact investigations and serosurveillance. Preprint. bioRxiv.
<https://doi.org/10.1101/2020.04.24.057323>
5. 2020) Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489-1501.
< , A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., Marrama, D., de Silva, A. M., Frazier, A., Carlin, A. F., Greenbaum, J. A., Peters, B., Krammer, F., Smith, D. M., Crotty, S., Sette, A. (https://doi.org/10.1016/j.cell.2020.05.015>
6. 2019) Strategies of adoptive T-cell transfer to treat refractory viral infections post allogeneic stem cell transplantation. J. Hematol. Oncol. 12, 13.
< , T., Krauss, R., Blaeschke, F., Willier, S., Feuchtinger, T. (https://doi.org/10.1186/s13045-019-0701-1>
7. 2020) The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. J. Gen. Virol. 101, 791-797.
< , P., Barclay, W. (https://doi.org/10.1099/jgv.0.001439>
8. 2004) Analysis of antigenspecific T-cell responses with synthetic peptides – what kind of peptide for which purpose? Hum. Immunol. 65, 523-536.
< , F., Streitz, M., Ay, B., Cherepnev, G., Volk, H. D., Volkmer-Engert, R., Kern, F. (https://doi.org/10.1016/j.humimm.2004.02.017>
9. Leung, W., Soh, T. G., Linn, Z. C., Low, J. G.-H., Loh, J., Chan, M., Chng, W. J., Koh, L. P., Poon, M. L.-M., Ng, K. P., Kuick, C. H., Tan, T. T., Tan, L. K., Seng, M. S-f. (2020) Successful manufacturing of clinical grade SARS-CoV-2 specific T cells for adoptive T cell therapy. Preprint. medRxiv.
<https://doi.org/10.1101/2020.04.24.20077487>
10. 2020) Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 26, 845-848.
< , Q. X., Liu, B. Z., Deng, H. J., Wu, G. C., Deng, K., Chen, Y. K., Liao, P., Qiu, J. F., Lin, Y., Cai, X. F., Wang, D. Q., Hu, Y., Ren, J. H., Tang, N., Xu, Y. Y., Yu, L. H., Mo, Z., Gong, F., Zhang, X. L., Tian, W. G., Hu, L., Zhang, X. X., Xiang, J. L., Du, H. X., Liu, H. W., Lang, C. H., Luo, X. H., Wu, S. B., Cui, X. P., Zhou, Z., Zhu, M. M., Wang, J., Xue, C. J., Li, X. F., Wang, L., Li, Z. J., Wang, K., Niu, C. C., Yang, Q. J., Tang, X. J., Zhang, Y., Liu, X. M., Li, J. J., Zhang, D. C., Zhang, F., Liu, P., Yuan, J., Li, Q., Hu, J. L., Chen, J., Huang, A. L. (https://doi.org/10.1038/s41591-020-0897-1>
11. 2007) A contemporary view of coronavirus transcription. J. Virol. 81, 20-29.
< , S. G., Sawicki, D. L., Siddell, S. G. (https://doi.org/10.1128/JVI.01358-06>
12. 2020) Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev. Mol. Diagn. 20, 453-454.
< , A., Ardebili, A. (https://doi.org/10.1080/14737159.2020.1757437>
13. 2020) Comparison of seven commercial RT-PCR diagnostic kits for COVID-19. J. Clin. Virol. 128, 104412.
< , P. B., van der Veer B., van den Brink, S., Wijsman, L., de Jonge, J., van den Brandt, A., Molenkamp, R., Reusken, C. B. E. M., Meijer, A. (https://doi.org/10.1016/j.jcv.2020.104412>
14. 2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260-1263.
< , D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C. L., Abiona, O., Graham, B. S., McLellan, J. S. (https://doi.org/10.1126/science.abb2507>
15. 2007) Duration of antibody responses after severe acute respiratory syndrome. Emerg. Infect. Dis. 13, 1562-1564.
< , L. P., Wang, N. C., Chang, Y. H., Tian, X. Y., Na, D. Y., Zhang, L. Y., Zheng, L., Lan, T., Wang, L. F., Liang, G. D. (https://doi.org/10.3201/eid1310.070576>